David is the CEO and co-founder of Acacia Mental Health, a practice focused on bringing hope to the hopeless. In 2021, he led the clinic in bringing a revolutionary 5-day treatment from Stanford (SAINT/SNT) out of the lab into clinical practice, calling it HOPE-TMS. Today, people fly in from all over the country to find relief from otherwise intractable depression and anxiety. The clinic continues to grow in scope and scale and has launched the Acacia Research Clinic (ARC), engaging in formal research directly.David originally studied engineering with the intent of becoming a medical missionary. He was accepted to Stanford Med, and then took a leave of absence to work for Nuru in Kenya combatting extreme poverty. While there, he realized that the Kenyans looked to the US, for better and worse, as an example. He decided to return to the US to focus on trying to help the US set a good example in practice and thought. Upon returning he studied under Amit Etkin and developed a love of neuroscience, doing work on the similarities between mental illnesses and on TMS. There, he realized the world-changing power of the technology. He then trained at Stanford Psychiatry as a resident. He launched Acacia Mental Health with Nathan Meng upon graduation.